Victory seeks to further leverage its successful commercial operations by acquiring or licensing approved pain management and related therapeutics, as well as by developing new products. Victory has chosen a 505(b)(2) regulatory approach that reduces product development risk and cost, while providing innovative treatments for pain and related indications.
Partnering is a fundamental part of Victory’s business strategy. To learn more about partnering with Victory, click here.
